2013年国际抗癫痫该协会抗癫痫药使用指南
2022-04-27 01:18:33 来源: 潮州 咨询医生
he purpose of this report was to update the 2006 International League Against Epilepsy (ILAE) report and identify the level of evidence for long-term efficacy or effectiveness for antiepileptic drugs (AEDs) as initial monotherapy for patients with newly diagnosed or untreated epilepsy. All applicable articles from July 2005 until March 2012 were identified, evaluated, and combined with the previous ysis (Glauser et al., 2006) to provide a comprehensive update.
The prior ysis methodology was utilized with three modifications: (1) the detectable noninferiority boundary approach was dropped and both failed superiority studies and prespecified noninferiority studies were yzed using a noninferiority approach, (2) the definition of an adequate comparator was clarified and now includes an absolute minimum point estimate for efficacy/effectiveness, and (3) the relationship table between clinical trial ratings, level of evidence, and conclusions no longer includes a recommendation column to reinforce that this review of efficacy/evidence for specific seizure types does not imply treatment recommendations.
This evidence review contains one clarification: The commission has determined that class I superiority studies can be designed to detect up to a 20% absolute (rather than relative) difference in the point estimate of efficacy/effectiveness between study treatment and comparator using an intent-to-treat ysis. Since July, 2005, three class I randomized controlled trials (RCT) and 11 class III RCTs he been published. The combined ysis (1940-2012) now includes a total of 64 RCTs (7 with class I evidence, 2 with class II evidence) and 11 meta-yses.
New efficacy/effectiveness findings include the following: levetiracetam and zonisamide he level A evidence in s with partial onset seizures and both ethosuximide and valproic acid he level A evidence in children with childhood absence epilepsy.
There are no major changes in the level of evidence for any other subgroup. Levetiracetam and zonisamide join carbamazepine and phenytoin with level A efficacy/effectiveness evidence as initial monotherapy for s with partial onset seizures. Although ethosuximide and valproic acid now he level A efficacy/effectiveness evidence as initial monotherapy for children with absence seizures, there continues to be an alarming lack of well designed, properly conducted epilepsy RCTs for patients with generalized seizures/epilepsies and in children in general.
These findings reinforce the need for multicenter, multinational efforts to design, conduct, and yze future clinically relevant adequately designed RCTs. When selecting a patient's AED, all relevant variables and not just efficacy and effectiveness should be considered.
查看信源IP
- 2022-05-05发作治疗的常见误区有哪些?
- 2022-05-02乙肝的传染间接地 6种间接地成乙肝传染重灾区(2)
- 2022-04-272013年国际抗癫痫该协会抗癫痫药使用指南
- 2021-11-04癫痫病饮食治疗法包含哪些以下内容
- 17 年度经验:随访胡须斑秃预后
- 中华医学会系列精选指南|急性腹痛、淋巴瘤、银屑病的诊断和治疗
- 女性月经保健 月经期间小心带来妇科疾病
- 外阴肿痛不好意思看?说明很受伤!
- 高考食谱 吃对食物,实现高考梦(13)
- Nucala(mepolizumab)首个能显著减少高嗜酸性粒细胞综合征患者耀斑的治疗方法
- 怀孕和产后有哪些问题 长辈的观念和现在的医学科学方法有很大的不同?
- JAMA Cardiol: 新冠肺炎心血管疾病的死亡率超过10%!天坛医院金泽宁发文认为有六个原因
- 烧口综合征注意事项!
- 白癜风症状 有些白斑可以预防白癜风
- 能治疗白癜风吗?
- 癫痫患者停药问题解决了吗?最新的预测模型已经发布!
- 如何预防白癜风?!
- 综述:癫痫持续状态诊治最新进展
- Medpage Today:不同类型的抗癫痫药物更有利
- 十个女人,八个贫血,五种常见的便宜货,让你充满气血
- 妇科疾病的到来有一个信号,女性在早上排尿时应该保持警惕。也许它来了
- 癫痫猝死:凶手是谁?
- FDA批准塞尔基因Otezla治疗银屑病性关节炎
- 专家回答,如何诊断儿童白癜风?
- 癫痫患者手术评估新型工具
- 甲硝唑 VS 替硝唑,只是一字之差吗?
- 治疗白癜风的方法很多
- 预测癫痫患者再入院风险
- 不注意这些问题,吃多少药都没用!
- 癫痫治疗障碍仍难以克服
- JAMA:阳性结果的文章一定更受关注吗?
- 癫痫患者腊月期间的饮食问题
- 戴只电器就能测癫痫发作?智能穿戴设备太牛了
- 确诊学习:典型拉福拉病一例
- 帕金森氏症的病因有很多
- 后天最初癫痫病症状能治疗吗
- 癫痫病需要怎样来进行确诊
- 早期病症能治好吗
- 不同样这些问题,吃多少药都没用!
- 延误型癫痫发作患者卒中预后更差
- 第九届 CAAE 国际癫痫论坛圆满举行,西方抗癫痫事业开启新篇章
- 专家谈有哪些癫痫病的有鉴于此
- 太原癫痫病医院:癫痫患者冬季易造成病情频繁发作
- 癫痫病的治疗方法是什么 癫痫病有这些偏方